In this study, we aim to investigate whether PRR plays a role during different stages of DN (from early to end stage) and during losartan (AT1R blockade) treatment, especially in the setting of high glucose and Ang II-related renal fibrosis in vivo and in vitro. The gene discussed is ATP6AP2; the disease is liver dysplastic nodule.